Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Yuan RR, Zhang Y, Zhang Y, Gou ST, Yu YH, Hao RY, An N, Guo JS, Chang XL, Xu XL, Dong C, Li J, Xue LY. Lifestyle factors, obesity, and Helicobacter pylori infection in gastric cancer by anatomical subsite: A systematic review and meta-analysis. World J Clin Oncol 2026; 17(11): 123888 [DOI: 10.5306/wjco.123888]
Rui-Rui Yuan, Yu Zhang, Shu-Ting Gou, Na An, Li-Ying Xue, Department of Pathology, Hebei Medical University, Shijiazhuang 050000, Hebei Province, China
Yi Zhang, Department of Public Health, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China
Yi-Hang Yu, Rong-Yao Hao, Basic Medicine School, Hebei Medical University, Shijiazhuang 050000, Hebei Province, China
Jia-Shuo Guo, Xiao-Lin Chang, Xin-Long Xu, Chang Dong, Jie Li, Department of Hematology, Hebei General Hospital, Shijiazhuang 050000, Hebei Province, China
Author contributions: Yuan RR designed research, analyzed data, and wrote the paper; Zhang Y analyzed data and wrote the paper; Zhang Y analyzed data and wrote the paper; Gou ST performed research, analyzed data, and wrote the paper; Yu YH designed research and analyzed data; Hao RY performed research and wrote the paper; An N performed research and wrote the paper; Guo JS analyzed data and wrote the paper; Chang XL performed research and wrote the paper; Xu XL performed research and wrote the paper; Dong C designed research and contributed new reagents or analytic tools; Li J designed research and wrote the paper; Xue LY designed research and wrote the paper. Yuan RR and Zhang Y contributed equally to this work as co-first authors. Both co-corresponding authors contributed equally to the conceptualization, study design, and overall supervision of the work, and they share joint responsibility for the scientific integrity of the study. We believe this arrangement accurately reflects their collaborative leadership and is consistent with the journal’s policy.
AI contribution statement: The authors take full responsibility and accountability for all content of this manuscript, including any portions for which AI tools were used as assistive technologies. All AI-assisted outputs were carefully reviewed, validated, and approved by the authors. AI tools were not used to generate original scientific data, perform independent scientific analyses, or draw scientific conclusions.
Supported by Natural Science Foundation of Hebei Province, No. H2021206395.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2020 Checklist statement: The authors have read the PRISMA 2020 Checklist, and the manuscript was prepared and revised according to the PRISMA 2020 Checklist.
Corresponding author: Li-Ying Xue, PhD, Professor, Department of Pathology, Hebei Medical University, No. 361 Zhongshan Eastern Road, Shijiazhuang 050000, Hebei Province, China. xueliying123@163.com
Received: June 5, 2026 Revised: August 31, 2026 Accepted: November 5, 2026 Published online: November 24, 2026 Processing time: 165 Days and 16.6 Hours
Abstract
BACKGROUND
Unhealthy lifestyle factors, obesity, and Helicobacter pylori (H. pylori) infection are established risk factors for gastric cancer, however, their differential associations with cardia gastric adenocarcinoma (CGA) and non-CGA (NCGA) remain inconsistent across studies.
AIM
To evaluate the subsite- and ethnicity-specific associations of lifestyle factors, obesity, and H. pylori infection with CGA and NCGA risk.
METHODS
We systematically searched MEDLINE, EMBASE, and Web of Science up to November 2025. Study quality was assessed using the Newcastle-Ottawa Scale, and publication bias was evaluated using funnel plots. Pooled odds ratios (OR) and 95% confidence interval (CI) were calculated. Subgroup analyses were conducted by ethnicity (East Asian vs European).
RESULTS
Twenty-six high-quality studies were included. Smoking was associated with increased risks of CGA (OR =1.99, 95%CI: 1.52-2.61; P < 0.00001) and NCGA (OR = 1.51, 95%CI: 1.25-1.84; P < 0.0001). Alcohol consumption was also associated with an increased risk of CGA (OR = 1.26, 95% CI: 1.04-1.53; P = 0.02), but was not significantly associated with the risk of NCGA (OR = 1.09, 95% CI: 0.77-1.53; P = 0.64). Higher body mass index (BMI) was significantly associated with CGA (OR = 1.43, 95%CI: 1.03-1.98; P = 0.03). H. pylori infection was not significantly associated with overall CGA risk (OR = 0.99, 95%CI: 0.59-1.65; P = 0.96) but significantly increased NCGA risk (OR = 2.49, 95%CI: 1.69-3.66; P < 0.00001). By ethnicity, H. pylori was associated with increased CGA risk in East Asian populations (OR = 2.45, 95%CI: 1.43-4.20; P = 0.001) but decreased it in European populations (OR = 0.46, 95%CI: 0.29-0.72; P = 0.0007), and increased NCGA risk in both groups.
CONCLUSION
Gastric cancer risk factors show subsite- and ethnicity-specific associations. Smoking significantly increases both CGA and NCGA risks. Alcohol consumption and higher BMI are significantly associated with increased CGA risk but not NCGA risk. H. pylori infection was not significantly associated with overall CGA but showed divergent associations by ethnicity, and consistently increased NCGA risk. These observations may help inform future risk‑stratified analyses and generate hypotheses for site‑ and ethnicity‑targeted gastric cancer prevention strategies.
Core Tip: This meta-analysis reveals that gastric cancer risk factors differ by anatomical subsite and ethnicity. Smoking significantly increases the risk of both cardia gastric adenocarcinoma (CGA) and non-CGA (NCGA). Alcohol consumption and higher body mass index are significantly associated with increased CGA risk but not NCGA risk. Helicobacter pylori infection shows opposite effects on CGA between East Asian and European populations but consistently increases NCGA risk. These findings support subsite-specific and ethnicity-specific prevention strategies.
Citation: Yuan RR, Zhang Y, Zhang Y, Gou ST, Yu YH, Hao RY, An N, Guo JS, Chang XL, Xu XL, Dong C, Li J, Xue LY. Lifestyle factors, obesity, and Helicobacter pylori infection in gastric cancer by anatomical subsite: A systematic review and meta-analysis. World J Clin Oncol 2026; 17(11): 123888
Gastric cancer is one of the most diagnosed malignancies worldwide, with approximately 1 million new cases and 800000 deaths annually[1]. Its incidence and prognosis differ markedly by anatomical subsite, particularly in high-prevalence regions such as East Asia, South America, and Central and Eastern Europe[2]. In recent decades, the global incidence of adenocarcinomas of the esophagogastric junction (AEGs), which include tumors arising from the distal esophagus and proximal stomach, has markedly increased[3,4]. AEGs are subclassified according to the Siewert classification: Siewert type I (distal esophageal adenocarcinoma), type II (true cardia gastric adenocarcinoma, CGA), and type III (subcardial gastric adenocarcinoma). In clinical and epidemiological reports on gastric cancer, Siewert type II and type III tumors, (with Siewert type II constituting the predominant proportion) are still collectively referred to as CGA. Recently, the incidence of CGA has been reported to be rising, while that of non‑CGA (NCGA) has declined[5]. CGA has become the predominant subtype in high-risk areas of China, particularly among older men. This divergent epidemiological pattern suggests that CGA and NCGA have distinct etiological mechanisms that require further clarification.
Biologically, CGA and NCGA are increasingly recognized as distinct entities with divergent carcinogenic pathways[3,6,7]. Etiologically, CGA, which arises at the gastroesophageal junction, is mainly associated with gastroesophageal reflux disease, exacerbated by obesity[8]. In contrast, NCGA originates in the gastric body or antrum and is classically linked to Helicobacter pylori (H. pylori) infection, wherein chronic active gastritis progresses through multifocal atrophy, intestinal metaplasia, and dysplasia[6]. Clinically, CGA exhibits deeper wall penetration, more frequent lymph node metastasis, and poorer prognosis than NCGA[9,10]. We previously demonstrated significant differences in cytokeratin and mucin immunophenotypes, as well as in p16INK4aRb and INK4a/ARF methylation, between CGA and NCGA[11]. These biological and clinical distinctions imply that modifiable risk factors may exert divergent effects on CGA and NCGA; however, subsite-specific evidence remains inconsistent.
Unhealthy lifestyle factors, including smoking and alcohol consumption, together with obesity, expressed as high body mass index (BMI), and H. pylori infection, are major modifiable risk factors for gastric cancer[6,7]. However, previous studies have reported inconsistent associations between these factors and the risks of CGA and NCGA. The causal role of H. pylori in NCGA is well established, whereas its association with CGA remains controversial, with studies reporting positive, null, or inverse associations[3,12-14]. In addition, ethnic and geographic differences in these associations have rarely been evaluated systematically.
To address these gaps, we conducted a systematic review and meta-analysis to quantify the associations of smoking, alcohol consumption, BMI, and H. pylori infection with the risks of CGA and NCGA. We also performed ethnic subgroup analyses comparing East Asian and European populations to explore potential heterogeneity. Our findings may improve risk stratification, guide personalized prevention, and optimize clinical management strategies for CGA and NCGA, thereby helping to reduce the global burden of gastric cancer.
MATERIALS AND METHODS
Study protocol
This meta-analysis systematically reviewed high-quality studies evaluating the associations of smoking, alcohol consumption, BMI/obesity, and H. pylori infection with gastric cancer risk by anatomical subsite. The review included an extensive search of relevant cohort, nested case-control, case-cohort, and traditional case-control studies across multiple databases.
Search strategy
We conducted a comprehensive search of English-language literature in MEDLINE, EMBASE, and Web of Science databases until November 2025, without restrictions on publication date or region. The search terms included stomach cancer, gastric cancer, CGA, NCGA, smoking, alcohol consumption, obesity, BMI, and H. pylori. The complete search strategies for each database are provided in Supplementary Table 1.
Inclusion and exclusion criteria
Studies were eligible if they met the following criteria: (1) Clinical studies of adults aged ≥ 18 years; (2) Evaluation of smoking, alcohol consumption, BMI, or H. pylori infection as exposures; (3) Reporting of risk estimates, including odds ratios (ORs) or relative risks, with 95% confidence intervals (CIs) for CGA and/or NCGA; and (4) Cohort, nested case-control, case-cohort, or traditional case-control study design. Nested case-control and case-cohort studies were considered cohort-based designs because they were derived from defined cohorts and provided risk estimates compatible with cohort evidence. Only studies published in English were included. Studies were excluded if they lacked a control group, provided insufficient data, or did not classify tumors by subsite as CGA or NCGA. When multiple publications from the same cohort were identified, we included only the study with the largest sample size or the most complete data to avoid double-counting participants.
Data extraction and quality assessment
Each author assessed the search results for eligibility and study selection. Two reviewers independently extracted data, and disagreements were resolved through discussion with a third senior author. Extracted data included the first author’s name, publication year, total sample size, study location, follow-up duration, number of cases, case outcome, and other relevant study characteristics. ORs and 95%CIs were also extracted to quantify the associations between the selected risk factors and gastric cancer by subsite. The definitions and categorization of the exposure variables across the included studies are summarized in Supplementary Table 2. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS) for observational studies. The NOS evaluates three domains: Selection (0-4 points), comparability (0-2 points), and ascertainment (0-3 points; exposure for case-control studies, outcome for cohort studies), with a maximum total score of 9. Studies scoring ≥ 7 were considered high quality.
Statistical analysis
Pooled ORs and 95%CIs were calculated using inverse-variance weighting. A random-effects model was used as the primary approach; a fixed-effect model was used when I² ≤ 50% and clinical/methodological homogeneity was considered plausible. For analyses with substantial heterogeneity (I² > 50%), the random-effects model was adopted to yield more conservative summary estimates. Heterogeneity was assessed using the I² statistic and explored through subgroup analyses by ethnicity and study design, as well as sensitivity analyses stratified by study design. Publication bias was evaluated using funnel plots. Analyses were performed using RevMan 5.4 (The Cochrane Collaboration, Denmark). Statistical significance was defined as P < 0.05. No missing summary statistics were encountered from included studies, and no additional data conversions were performed before data synthesis. The certainty of evidence for pooled outcomes was assessed using the GRADE approach, and the results are presented in Supplementary Table 3.
RESULTS
Literature search and study selection
The initial database search identified 1894 candidate studies. After duplicate removal, 842 unique records remained. After reviews, meta-analyses, and other ineligible article types were excluded, 589 records underwent initial screening. Screening of titles and abstracts led to the exclusion of 323 articles, leaving 266 articles for full-text evaluation. Of 240 excluded full-text articles, 156 lacked relevant outcome data, 28 had an ineligible study population, 25 had an inappropriate study design, 19 were ineligible publication types, and 12 had a non-matching exposure, leaving 26 studies for the final meta-analysis. The detailed screening process is shown in Figure 1. Detailed reasons for exclusion and a summary of excluded full-text reports are provided in Supplementary Table 4.
Figure 1
Flow diagram of the literature search and selection.
Characteristics of included studies
The meta-analysis included 26 eligible studies. According to the original study design, these comprised 14 cohort studies (11 prospective, 2 pooled prospective, and 1 retrospective), 4 nested case-control studies, 1 case-cohort study, and 7 traditional case-control studies. For analysis, nested case-control and case-cohort studies were classified within the cohort framework, yielding 19 cohort-based studies and 7 traditional case-control studies[15-40]. The studies were conducted in China, the United States, Japan, Germany, the United Kingdom, South Korea, and other countries. Publication years ranged from 1991 to 2025. The baseline characteristics of the included studies are presented in Table 1.
Table 1 Baseline characteristics of the included studies.
The associations between cigarette smoking and the CGA and NCGA subtypes were examined using data from six studies, including 528956 participants in the exposure groups and 661726 participants in the control groups. Detailed results are presented in the forest plots in Figure 2. Smoking was associated with significantly increased risks of both CGA (OR = 1.99, 95%CI: 1.52-2.61; P < 0.00001) and NCGA (OR = 1.51, 95%CI: 1.25-1.84; P < 0.0001).
Figure 2 Association of smoking with gastric cancer.
Forest plots of the odds ratio showed that smoking significantly increases the risk of cardia gastric adenocarcinoma (CGA) and non-CGA (NCGA). A: CGA; B: NCGA. Data were pooled from 6 studies using a random-effects model (Mantel-Haenszel). Heterogeneity: CGA, I² = 64%, P < 0.00001; NCGA, I² = 68%, P < 0.0001. CGA: Cardia gastric adenocarcinoma; NCGA: Non-cardia gastric adenocarcinoma; CI: Confidence interval.
Alcohol consumption
Six studies, including 490244 participants in the exposure groups and 485704 participants in the control groups, were analyzed to evaluate the association between alcohol consumption and gastric cancer risk by anatomical subsite (Figure 3). For CGA, the pooled OR was 1.26 (95%CI: 1.04-1.53), indicating a statistically significant 26% increase in risk associated with alcohol consumption (P = 0.02). For NCGA, alcohol consumption was not significantly associated with increased risk (OR = 1.09, 95%CI: 0.77-1.53; P = 0.64). Notably, alcohol‑related risk differed by gastric cancer subsite, with a significant association observed only for CGA.
Figure 3 The relationships of alcohol consumption with gastric cancer.
A: Forest plots showed that alcohol consumption significantly increases the incidence risk of cardia gastric adenocarcinoma (CGA); B: Alcohol consumption was not significantly associated with non-CGA (NCGA). Data were pooled from 6 studies using a fixed-effect model for CGA and a random-effects model for NCGA (Mantel-Haenszel) due to substantial heterogeneity in NCGA. Heterogeneity: CGA, I2 = 30%, P = 0.02; NCGA, I2 = 82%, P = 0.64. CGA: Cardia gastric adenocarcinoma; NCGA: Non-cardia gastric adenocarcinoma; CI: Confidence interval.
BMI
Six studies were included to evaluate the association between BMI and gastric cancer risk stratified by anatomical subsite (Figure 4). The random-effects analysis, which included 156846 participants and 193 cases, showed a significant positive trend towards an association between higher BMI and CGA (OR = 1.43, 95%CI: 1.03-1.98; P = 0.03). In contrast, six studies of NCGA, comprising 358 cases among 190829 participants, showed no significant association with higher BMI (OR = 1.03, 95%CI: 0.93-1.15; P = 0.56). These findings indicate that higher BMI is significantly associated with increased CGA risk but not NCGA risk.
Figure 4 The relationships of body mass index with gastric cancer.
A: Forest plots showed that higher body mass index was significantly associated with an increased risk of cardia gastric adenocarcinoma (CGA); B: No significant association was observed with non-CGA (NCGA). Data were pooled from 6 studies (CGA) and 6 studies (NCGA) using a random-effects model for CGA and a fixed-effect model for NCGA (Mantel-Haenszel) due to substantial heterogeneity in CGA. Heterogeneity: CGA, I2 = 65%, P =0.03; NCGA, I2 = 34%, P = 0.56. CGA: Cardia gastric adenocarcinoma; NCGA: Non-cardia gastric adenocarcinoma; BMI: Body mass index; CI: Confidence interval.
Associations of H. pylori infection with CGA and NCGA
Because H. pylori infection is an established risk factor for NCGA but its etiological role in CGA remains controversial, we performed a meta-analysis to evaluate its associations with both gastric cancer subsites (Figure 5). H. pylori infection was not significantly associated with overall CGA risk (OR = 0.99, 95%CI: 0.59-1.65; P = 0.96), but was significantly associated with increased NCGA risk (OR = 2.49, 95%CI: 1.69-3.66; P < 0.00001).
Figure 5 The relationships of Helicobacter pylori infection with gastric cancer.
A: Forest plots of the odds ratio showed that Helicobacter pylori (H. pylori) infection was not significantly associated with cardia gastric adenocarcinoma (CGA); B: H. pylori infection significantly increased the risk of non-CGA (NCGA). Data were pooled from 10 studies (CGA) and 14 studies (NCGA) using a random-effects model (Mantel-Haenszel) due to substantial heterogeneity. Heterogeneity: CGA, I2 = 88%, P = 0.96; NCGA, I2 = 91%, P < 0.00001. CGA: Cardia gastric adenocarcinoma; NCGA: Non-cardia gastric adenocarcinoma; H. pylori: Helicobacter pylori; CI: Confidence interval.
Because of the genetic diversity of H. pylori and geographic variation in its prevalence, we conducted subgroup analyses by ethnicity (East Asian vs European). In the East Asian subgroup, H. pylori infection significantly increased CGA risk (OR = 2.45, 95%CI: 1.43-4.20; P = 0.001; Figure 6). Conversely, in the European subgroup, H. pylori infection was associated with decreased CGA risk (OR = 0.46, 95%CI: 0.29-0.72; P = 0.0007). For NCGA, H. pylori infection significantly increased risk in both East Asian populations (OR = 3.04, 95%CI: 2.21-4.20; P < 0.00001) and European populations (OR = 2.97, 95%CI: 2.18-4.05; P < 0.00001).
Figure 6 Subgroup analysis of Helicobacter pylori infection in gastric adenocarcinoma and non-cardia gastric adenocarcinoma.
A and B: Helicobacter pylori (H. pylori) infection was significantly associated with an increased risk of cardia gastric adenocarcinoma (CGA) in East Asians and with a decreased risk in Europeans; C and D: H. pylori infection significantly increased the risk of non-CGA in East Asians and in Europeans. Data were pooled using random-effects models for the East Asian subgroups and fixed-effects models for the European subgroups (Mantel-Haenszel) based on heterogeneity. H. pylori: Helicobacter pylori; CGA: Cardia gastric adenocarcinoma; NCGA: Non-cardia gastric adenocarcinoma; CI: Confidence interval.
Heterogeneity and publication bias
Analyses of heterogeneity and publication bias showed substantial variation across several risk factors. For example, the analyses of H. pylori infection showed high heterogeneity, indicating substantial differences among the included studies. Study quality was assessed using the NOS, with details presented in Supplementary Figures 1 and 2. Leave-one-out sensitivity analyses showed that sequential exclusion of individual studies did not materially change the direction or magnitude of the pooled estimates for any primary association, indicating that the findings were robust to the influence of any single study (Supplementary Tables 5-12). To further assess the robustness of our pooled estimates to potential unmeasured confounding, we calculated E‑values for each significant association; the results are presented in Supplementary Table 13. The GRADE certainty of evidence for each primary association is summarized in Supplementary Table 3.
DISCUSSION
Gastric cancer remains the fifth most common malignancy and the fourth leading cause of cancer-related death worldwide, with marked geographic and anatomical subsite variation in incidence and mortality[41]. The disease is particularly prevalent in East Asia, South America, and Eastern Europe, and shows a notable predominance among men. In recent decades, the epidemiological pattern of gastric cancer has shifted markedly: The incidence of CGA has been rising globally, whereas that of NCGA has declined in Western countries[3-5]. Our previous studies from high-risk regions for gastric and esophageal cancers in China further showed that CGA has become the dominant subtype, with an incidence up to fourfold higher than that of NCGA in Cixian County. This divergent trend strongly suggests that CGA and NCGA are distinct entities with different etiological backgrounds, although the underlying mechanisms remain incompletely understood. The present meta-analysis was therefore designed to clarify the subsite-specific associations of major modifiable risk factors, including smoking, alcohol consumption, BMI, and H. pylori infection, with CGA and NCGA. We also examined ethnic heterogeneity between East Asian and European populations.
Smoking and alcohol consumption
Cigarette smoking and alcohol consumption are well-recognized lifestyle risk factors for multiple upper gastrointestinal malignancies[6,21]. Our meta-analysis confirmed that smoking significantly increases the risk of CGA and NCGA, whereas alcohol consumption significantly increased CGA risk but not NCGA risk. Specifically, smoking was associated with a 1.99-fold higher risk of CGA and a 1.51-fold higher risk of NCGA, consistent with previous prospective cohort studies[17]. These findings support smoking as a strong risk factor across gastric cancer subsites, plausibly acting through chronic inflammation, oxidative stress, and DNA damage.
For alcohol consumption, existing evidence indicates that alcohol-related gastric cancer risk varies by ethnicity, dose, and beverage type[21,42,43]. The Continuous Update Report of the World Cancer Research Fund indicated that daily ethanol consumption of ≥ 45 g (about 3 drinks) increases gastric cancer risk, with each additional 10 g per day conferring a particularly elevated risk among Asians compared to other ethnic groups[21]. A Japanese systematic review of 11 cohort and 11 case-control studies reported that only one cohort study found a significant association between alcohol intake (≥ 50 mL/day) and gastric cancer risk [hazard ratio (HR) 3.05, 95%CI: 1.35-6.91] in men, whereas all other studies showed no significant association[42]. However, a Swedish prospective study of 61433 women (aged 39-76 years) found that beer consumption (> 1 serving of medium-strong or strong beer per week vs. none), but not total alcohol intake (≥ 40 g/week vs never drinkers), was associated with increased gastric cancer risk[43]. Meanwhile, both a history of alcohol consumption and smoking were more common in gastric cancer patients with submucosal invasion[44]. These findings suggest that the association between alcohol consumption and gastric cancer varies substantially across populations, exposure doses, and anatomical subsites. Our pooled results from diverse populations, including 490244 participants in the exposure groups and 485704 participants in the control groups from East Asia, Europe, and North America, indicate that alcohol consumption is a consistent risk factor for CGA. Collectively, these data indicate that tobacco control and alcohol restriction are broadly applicable strategies for reducing the burden of both CGA and NCGA.
BMI and obesity
Obesity is a major modifiable contributor to the global cancer burden[6], accounting for 4.8% of cases in men and 10.6% of cases in women[6]. Most recently, a retrospective cohort study of 333169 Korean adults with a median follow-up of 12 years showed that severe obesity (≥ 30.0 kg/m2) was associated with a 1.27-fold higher overall risk of gastric cancer compared with the reference BMI group (23.0-24.9 kg/m2) among men but not among women[22]. The proportion of esophageal and gastric cancers attributable to excess body weight was larger in men than in women, likely due to a higher prevalence of obesity-associated subtypes[6]. In women, the largest waist circumference category was associated with an increased overall gastric cancer risk (HR = 1.37, 95%CI: 1.07-1.74)[22]. In a Japanese population, overweight or obesity (BMI ≥ 25 kg/m²) was associated with a nonsignificant increase in esophageal adenocarcinoma risk (HR = 1.32, 95%CI: 0.80-2.17) and a significant increase in CGA risk (HR = 1.24, 95%CI: 1.05-1.46) compared with normal weight[23]. In a European cohort of 476,160 participants, waist-to-hip ratio in women and waist circumference in men were independently associated with CGA after BMI adjustment, suggesting that abdominal obesity may influence CGA risk and that some reproductive factors in women may specifically influence NCGA risk[24]. Our analysis showed that higher BMI was significantly associated with increased CGA risk (OR = 1.43), with no significant association with NCGA. This subsite-specific pattern aligns with previous studies from Japan and Europe[23,24], which linked abdominal obesity to CGA but not to distal gastric cancer. A plausible mechanism is that obesity promotes gastroesophageal reflux disease, a well-established precursor of CGA and esophageal adenocarcinoma. In contrast, NCGA is more closely linked to chronic H. pylori-associated corpus gastritis than to reflux. Our findings therefore strengthen the evidence that weight control is a targeted preventive measure specifically for CGA.
H. pylori infection
H. pylori is a Group I carcinogen and the dominant cause of NCGA, but its role in CGA has long remained controversial. Previous studies have reported null or reduced associations between H. pylori infection and both esophageal adenocarcinoma and CGA[3,12], whereas other studies have shown positive associations with CGA[13,14]. Our meta-analysis addressed this inconsistency by showing that H. pylori infection was significantly associated with NCGA, but not with overall CGA risk. More importantly, ethnic subgroup analysis revealed a striking divergence for CGA: In East Asian populations, H. pylori increased CGA risk (OR = 2.45), whereas in European populations, it was associated with reduced CGA risk (OR = 0.46). For NCGA, H. pylori consistently increased risk in both ethnic groups.
A Chinese cohort study of 29584 residents from Linxian, a high-incidence area for esophageal cancer, demonstrated similarly strong associations of H. pylori infection with both CGA (OR = 1.64, 95%CI: 1.26–2.14) and NCGA (OR = 1.60, 95%CI: 1.15-2.21)[32]. In Chinese populations, H. pylori infection is also linked to the severity of precancerous cardia lesions and elevated CGA risk[45,46]. By contrast, a Norwegian nested case-control study reported an inverse association between H. pylori and CGA (OR = 0.27, 95%CI: 0.12-0.59), although H. pylori-positive CGA cases were associated with gastric atrophy (OR = 3.33, 95%CI: 1.06-10.5)[30]. We speculate that these conflicting results may arise from differences in H. pylori virulence subtypes, host genetic susceptibility, and distinct pathophysiological backgrounds across geographic regions and anatomical subsites. However, this inverse association in Europeans may also reflect methodological factors, such as residual confounding, tumor misclassification, differences in the prevalence of reflux disease and obesity, or publication bias, rather than a true protective effect.
In high-risk Chinese populations with high H. pylori prevalence, the proportion of CGA has increased markedly. In these regions, abnormal serum pepsinogen (PG) levels and H. pylori positivity are all linked to higher gastric cancer risk[47]. Our previous retrospective studies further confirmed that CGA has become the predominant gastric cancer subtype, especially among older men. Although H. pylori infection rates did not differ between CGA and NCGA, the prevalence of VacA-positive strains was significantly higher in CGA than in distal gastric cancer, supporting a pathogenic role of VacA-positive H. pylori in CGA[14].
These findings indicate that H. pylori contributes substantially to gastric carcinogenesis in China, particularly to CGA in high-prevalence areas. Together with the rising prevalence of obesity and population aging, persistent H. pylori infection may help explain the increasing incidence of CGA in contemporary Chinese populations. Notably, by distinguishing CGA from NCGA, our findings extend prior meta-analyses that pooled overall gastric cancer and reveal ethnicity-specific associations that were previously obscured.
Limitations
Several limitations should be acknowledged. First, some analyses showed substantial heterogeneity despite subgroup stratification. Second, individual-level confounders, including age, sex, and dietary factors, were not consistently available across the included studies. Third, some subgroups included relatively few studies, which may limit the precision of subgroup-specific estimates. Fourth, this meta-analysis was based on binary or categorical exposure contrasts. We did not perform dose-response analyses because the original studies used inconsistent metrics and cutoffs for smoking intensity, alcohol quantity, and BMI categories. Future pooled analyses using harmonized dose data are warranted. Fifth, most studies focused on high-risk populations, which may limit generalizability to low-risk regions. Finally, although this systematic review was not prospectively registered and no formal pre-study protocol was developed before this meta-analysis (with no subsequent amendments), we strictly adhered to the PRISMA 2020 guidelines throughout the search, screening, analysis, and reporting phases. Despite these limitations, this study represents the most comprehensive meta-analysis to date of subsite-specific and ethnicity-specific risk factors for gastric cancer and provides robust evidence for clinical practice.
CONCLUSION
This meta-analysis shows that major gastric cancer risk factors have subsite-specific and ethnicity-specific associations. Smoking significantly increases the risks of both CGA and NCGA, whereas alcohol consumption and higher BMI are significantly associated with CGA risk but not NCGA risk. H. pylori infection consistently increases NCGA risk, whereas its association with CGA differs by ethnicity, increasing risk in East Asian populations and decreasing risk in European populations. These distinct risk profiles support the classification of CGA and NCGA as separate disease entities with different etiological mechanisms. Our findings provide observational evidence to inform precision risk stratification, targeted prevention, and personalized clinical management of gastric cancer.
Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, Rakhshani N, Didevar R, Sotoudeh M, Zolfeghari AA, McColl KE. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer.Gut. 2008;57:298-305.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 147][Cited by in RCA: 142][Article Influence: 7.9][Reference Citation Analysis (8)]
Buckland G, Travier N, Huerta JM, Bueno-de-Mesquita HB, Siersema PD, Skeie G, Weiderpass E, Engeset D, Ericson U, Ohlsson B, Agudo A, Romieu I, Ferrari P, Freisling H, Colorado-Yohar S, Li K, Kaaks R, Pala V, Cross AJ, Riboli E, Trichopoulou A, Lagiou P, Bamia C, Boutron-Ruault MC, Fagherazzi G, Dartois L, May AM, Peeters PH, Panico S, Johansson M, Wallner B, Palli D, Key TJ, Khaw KT, Ardanaz E, Overvad K, Tjønneland A, Dorronsoro M, Sánchez MJ, Quirós JR, Naccarati A, Tumino R, Boeing H, Gonzalez CA. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study.Int J Cancer. 2015;137:598-606.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 110][Cited by in RCA: 97][Article Influence: 8.8][Reference Citation Analysis (5)]
Koyanagi YN, Matsuo K, Ito H, Wang C, Tamakoshi A, Sugawara Y, Tsuji I, Ono A, Tsugane S, Sawada N, Wada K, Nagata C, Takeuchi T, Kitamura T, Utada M, Sakata R, Mizoue T, Abe SK, Inoue M; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan.Cancer Sci. 2023;114:2961-2972.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 6][Cited by in RCA: 18][Article Influence: 6.0][Reference Citation Analysis (2)]
Sanikini H, Muller DC, Sophiea M, Rinaldi S, Agudo A, Duell EJ, Weiderpass E, Overvad K, Tjønneland A, Halkjaer J, Boutron-Ruault MC, Carbonnel F, Cervenka I, Boeing H, Kaaks R, Kühn T, Trichopoulou A, Martimianaki G, Karakatsani A, Pala V, Palli D, Mattiello A, Tumino R, Sacerdote C, Skeie G, Rylander C, Chirlaque López MD, Sánchez MJ, Ardanaz E, Regnér S, Stocks T, Bueno-de-Mesquita B, Vermeulen RCH, Aune D, Tong TYN, Kliemann N, Murphy N, Chadeau-Hyam M, Gunter MJ, Cross AJ. Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.Int J Cancer. 2020;146:929-942.
[RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)][Cited by in Crossref: 21][Cited by in RCA: 28][Article Influence: 4.7][Reference Citation Analysis (4)]
Gong J, Liu F, Peng Y, Wang P, Si C, Wang X, Zhou H, Gu J, Qin A, Song F. Sex disparity in the association between metabolic-anthropometric phenotypes and risk of obesity-related cancer: a prospective cohort study.BMC Med. 2024;22:355.
[RCA] [PubMed] [DOI] [Full Text][Cited by in RCA: 2][Reference Citation Analysis (0)]
Shakeri R, Malekzadeh R, Nasrollahzadeh D, Pawlita M, Murphy G, Islami F, Sotoudeh M, Michel A, Etemadi A, Waterboer T, Poustchi H, Brennan P, Boffetta P, Dawsey SM, Kamangar F, Abnet CC. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.Cancer Res. 2015;75:4876-4883.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 39][Cited by in RCA: 41][Article Influence: 3.7][Reference Citation Analysis (6)]
Yang L, Kartsonaki C, Yao P, de Martel C, Plummer M, Chapman D, Guo Y, Clark S, Walters RG, Chen Y, Pei P, Lv J, Yu C, Jeske R, Waterboer T, Clifford GM, Franceschi S, Peto R, Hill M, Li L, Millwood IY, Chen Z; China Kadoorie Biobank Collaborative Group. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study.Lancet Public Health. 2021;6:e888-e896.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 166][Cited by in RCA: 171][Article Influence: 34.2][Reference Citation Analysis (14)]
Shimazu T, Tsuji I, Inoue M, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsugane S; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Alcohol drinking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.Jpn J Clin Oncol. 2008;38:8-25.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 36][Cited by in RCA: 31][Article Influence: 1.7][Reference Citation Analysis (0)]
Sheikh M, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M, Gharavi A, Hashemian M, Roshandel G, Khademi H, Zahedi M, Abedi-Ardekani B, Boffetta P, Kamangar F, Dawsey SM, Pharaoh PD, Abnet CC, Day NE, Brennan P, Malekzadeh R. Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study.Gastroenterology. 2019;156:1416-1427.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 90][Cited by in RCA: 149][Article Influence: 21.3][Reference Citation Analysis (4)]
Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J, Xing X, Wang J, Du Z, Misumi J, Tian Q, Wang L. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.Int J Cancer. 2012;130:1614-1619.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 34][Cited by in RCA: 36][Article Influence: 2.6][Reference Citation Analysis (0)]
Footnotes
Peer review: Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Oncology
Country of origin: China
Peer-review report’s classification
Scientific quality: Grade B, Grade B, Grade D
Novelty: Grade A, Grade B, Grade D
Creativity or innovation: Grade B, Grade C, Grade D
Scientific significance: Grade A, Grade C, Grade D
P-Reviewer: Hassan AH, Academic Fellow, Egypt; Rao RSP, PhD, Professor, India S-Editor: Qu XL L-Editor: A P-Editor: Lei YY